NASDAQ · Medical - Devices

Insulet Corporation (PODD) Stock

$134.47 +0.08% NASDAQ: PODD Healthcare

Valuation

MetricValue
Price$134.47
Market Cap$9.31B
P/E Ratio24.57
P/B Ratio6.42
P/S Ratio2.99
EPS (TTM)$3.48
52-Week High$354.88
52-Week Low$126.40
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE26.69%
ROA11.86%
ROCE21.31%
Gross Margin17.50%
Operating Margin17.50%
Net Margin12.29%
Debt/Equity0.67
Current Ratio2.78

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.1B$1.3B$1.7B$2.1B$2.7B
Operating Profit$126.0M$38.0M$220.0M$309.0M$474.0M
Net Profit$17.0M$5.0M$206.0M$418.0M$247.0M
EPS$0.25$0.07$2.94$5.78$3.48
Op Margin11.5%2.9%13.0%14.9%17.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.0B$2.3B$2.6B$3.1B$3.2B
Total Liabilities$1.5B$1.8B$1.9B$1.9B$1.7B
Cash$792.0M$624.0M$651.0M$953.0M$716.0M
Borrowings$1.3B$1.4B$1.4B$1.4B$1.1B

Latest News

3 Quality Compounders on Our Buy List StockStory · Jul 15, 2026 PODD: Lowering target price to $175.00 Argus Research · Jul 15, 2026 Insulet, Calm Form Partnership Targeting Diabetes Community With Wellness Products MT Newswires · Jul 14, 2026 Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss Business Wire · Jul 14, 2026 Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insights GlobeNewswire · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-68.0M$119.0M$146.0M$430.0M$569.0M
Investing Cash Flow$-205.0M$-348.0M$-195.0M$-271.0M$-414.0M
Financing Cash Flow$-32.0M$-17.0M$-13.0M$-8.0M$79.0M
Net Cash Flow$-116.0M$-117.0M$15.0M$249.0M$-237.0M
Free Cash Flow$-191.0M$-38.0M$70.0M$305.0M$378.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.42
EV / EBITDA14.97
FCF Yield3.27%
Quick Ratio1.83
Interest Coverage8.14
Return 1Y-56.77%
Return 3Y-7.41%
Return 5Y-54.02%

Ownership

Insiders Held0.33%
Institutions Held104.99%
Institutions Float Held105.34%
Institutional HolderSharesReport Date
Blackrock Inc.6,375,9432026-03-31
Vanguard Capital Management LLC4,579,2742026-03-31
FMR, LLC3,974,7122026-03-31
Vanguard Portfolio Management LLC3,449,9872026-03-31
State Street Corporation3,042,4542026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BBNXBeta Bionics, Inc. $17.43 -3.60% -11.29 $784.17M 0.00%
DXCMDexCom, Inc. $84.41 +0.13% 33.44 $31.85B 0.00%
SENSSenseonics Holdings, Inc. $9.02 -1.53% -4.35 $376.98M 0.00%
TNDMTandem Diabetes Care, Inc. $15.68 -1.04% -17.53 $1.07B 0.00%

About Insulet Corporation

Insulet Corporation is led by CEO Ashley McEvoy, employs 5,400 people, headquartered in Acton, US, publicly traded since 2007.

Insulet Corporation (PODD) stock trades at $134.47 with a market capitalization of $9.31B. The stock is valued at a price-to-earnings (P/E) ratio of 24.57, price-to-book of 6.42, price-to-sales of 2.99. Over the past 52 weeks the stock has ranged between $126.40 and $354.88, and currently trades 62.1% below its 52-week high.

On profitability, Insulet Corporation generates a return on equity (ROE) of 26.69% — well above the market average, a sign of a high-quality business, return on capital employed of 21.31%, an operating margin of 17.50%, a net profit margin of 12.29%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1162.55 -0.60% JNJ Johnson & Johnson $257.43 +0.37% ABBV AbbVie Inc. $274.33 +0.70% MRK Merck & Company, Inc. Common Stock (new) $143.09 +0.50% UNH UnitedHealth Group Incorporated Common Stock (DE) $384.13 +3.55% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $656.66 +0.72% AMGN Amgen Inc. $406.05 -0.34% GILD Gilead Sciences, Inc. $147.20 +0.07% ABT Abbott Laboratories $98.92 +0.44% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides